Clinical presentation of exclusive cystic fibrosis lung disease

Thorax

Volumn 54, Issue 3, 1999, Pages 278-281

  Bronsveld, Inez ^a   Bijman, Jan ^a   Mekus, Frauke ^c   Ballmann, Manfred ^c   Veeze, Henk J ^b   Tümmler, Burkhard ^c  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Atypical cystic fibrosis; Cystic fibrosis; Genetics; Nasal potential difference

Indexed keywords

CHLORIDE ION; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; ARTICLE; CASE REPORT; CHLORIDE TRANSPORT; CLINICAL FEATURE; CYSTIC FIBROSIS; DIAGNOSTIC ACCURACY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOTE; HUMAN; LUNG DISEASE; NOSE; PHENOTYPE; POTENTIAL DIFFERENCE; PRIORITY JOURNAL; SYMPTOM;

EID: 0033031154     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.54.3.278     Document Type: Article

References (24)

1. Welsh MJ, Tsui LC, Boat TF, er al. Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular basis of inherited disease. New York: McGraw Hill, 1995:3799-876.
2. Bear CE, Li CH, Kartner N, et al. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell 1992;68:809-18.
3. Gibson LE, Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 1959;23:545-9.
4. Veeze HJ, Sinaasappel M, Bijman J, et al. Ion transport abnormalities in rectal suction biopsies from children with cystic fibrosis. Gastroenteralogy 1991;101:308-403.
5. Knowles MR, Carson JL, Collier AM, et al. Measurements of nasal transepithelial electrical potential differences in normal human subjects in vivo. Am Rev Respir Dis 1981;124:484-90.
6. Knowles MR, Paradiso AM, Boucher RC. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum Gene Ther 1995;6:445-55.
7. Gan KH, Veeze HJ, van den Ouweland AM, et al. A cystic fibrosis mutation associated with mild lung disease. N Engl J Med 1995;333:95-9.
8. Gilbert F, Li Z, Arzimanoglou I, et al. Clinical spectrum in homozygotes and compound heterozygotes inheriting cystic fibrosis mutation 3849 + 10kb C > T: significance for geneticists. Am J Med Genet 1995;58:356-9.
9. Kerem E, Rave-Harel N, Augarten A, et al. A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentations. Am J Respir Crit Care Med 1997;155:1914-20.
10. Veeze HJ, Halley DJ, Bijman J, et al. Determinants of mild clinical symptoms in cystic fibrosis patients. J Clin Invest 1994;93:461-6.
11. Dörk T, Mekus F, Schmidt K, et al. More than 50 different CFTR mutations in a large group of German cystic fibrosis patients. Hum Genet 1994;94:533-42.
12. Ravnik-Glavcak M, Glavcak D, Dean M. Sensitivity of single strand conformation polymorphism and heteroduplex method for mutation detection. Hum Mol Genet 1994;3:801-7.
13. Zielenski J, Rozmahel R, Bozon D, et al. Genomic sequence of the CFTR gene. Genomics 1991;10:214-28.
14. Bautsch W, Römling U, Schmidt KD, et al. Long-range restriction mapping of genomic DNA. In: Dear PH, ed. Genome mapping - a practical approach. Oxford: Oxford University Press, 1997:281-313.
15. Dörk T, Neumann T, Wulbrand U, et al. Intra- and extragenic marker haplotypes of CFTR mutations in cystic fibrosis families. Hum Genet 1992;88:417-25.
16. Cuppens H, Lin W, Jaspers M, et al. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. J Clin Invest 1998;101:487-96.
17. Tens H, Jorissen M, van Poppel H, et al. Increased proportion of exon 9 alternatively spliced CFTR transcript in vas deferens compared with nasal epithelial cells. Hum Mol Genet 1997;6:85-90.
18. Mortal N, Estivill X. Multiplex amplification of three microsatellites within the CFTR gene. Genomics 1992;13:1362-4.
19. Mekus F, Dörk T, Deufel T, et al. Analysis of microsatellites by direct blotting electrophoresis and chemiluminescence detection. Electrophoresis 1995;16:1886-8.
20. Knowles MR, Clarke LL, Boucher RC. Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. N Engl J Med 1991;325:533-8.
21. Knowles MR, Gatzy J, Boucher RC. Increased bioelectrical potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med 1981;305:1489-95.
22. Dreyfus DH, Bethel R, Gelfand EW. Cystic fibrosis 3849+10kb C > T mutation associated with severe pulmonary disease and male fertility. Am J Respir Crit Care Med 1996;153:858-60.
23. Highsmith WE, Butch LH, Zhou Z, et al. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N Engl J Med 1994;331:974-80.
24. Strong TV, Wilkinson DJ, Mansoura MK, et al. Expression of an abundant alternatively spliced form of the cystic fibrosis transmembrane conductance regulator (CFTR) gene is not associated with a cAMP-activated chloride conductance. Hum Mol Genet 1993;2:225-30.